Skip to main content
Back
Watch Compare

VitaNova Life Sciences Corp

Data quality: 100%
VNOV
OTC Wholesale Trade Nondurable Goods Wholesale
$4.83
$0.00 (0.00%)
Mkt Cap: 40.27 M
Price
$4.83
Mkt Cap
40.27 M
Day Range
—
52-Week Range
$0.42 — $7.50
Volume
—
Open —
50D / 200D Avg
$4.83
0.00% above
50D / 200D Avg
$3.31
45.98% above

Quick Summary

Key Takeaways

Earnings grew 503.94% over the past year
ROE of 39.74% indicates high profitability
Net margin of 23.34% shows strong profitability
Generating 865,231.0 in free cash flow
P/E of 54.02 — premium valuation
Cash machine — converts 116.06% of earnings into free cash flow

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)366.47%
Earnings (1Y)503.94%
FCF Growth (3Y)N/A

Quality

Return on Equity
39.74%
Above sector avg (-3.22%)
ROIC39.79%
Net Margin23.34%
Op. Margin37.44%

Safety

Debt / Equity
N/A
Current Ratio5.05
Interest Coverage762.57

Valuation

PE (TTM)
54.02
Above sector avg (-0.16)
P/B Ratio21.72
EV/EBITDA33.68
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Wholesale Trade sector median (91 peers)
Metric Stock Sector Median
P/E 54.0 -0.2
P/B 21.7 1.0
ROE % 39.7 -3.2
Net Margin % 23.3 -2.2
Rev Growth 5Y % — 3.6
D/E — 0.3

Analyst Price Target

No analyst coverage available

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2026 $0.03
N/A – N/A
 — —

All Fundamental Metrics
Growth
Revenue Growth (1Y) 366.47% Revenue Growth (3Y) 736.99%
Earnings Growth (1Y) 503.94% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 3.19 M Net Income (TTM) 745,479.0
ROE 39.74% ROA 32.08%
Gross Margin 56.46% Operating Margin 37.44%
Net Margin 23.34% Free Cash Flow (TTM) 865,231.0
ROIC 39.79% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 5.05
Interest Coverage 762.57 Asset Turnover 1.37
Working Capital 1.85 M Tangible Book Value 1.85 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 54.02 Forward P/E N/A
P/B Ratio 21.72 P/S Ratio 12.61
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 33.68 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 2.15%
Market Cap 40.27 M Enterprise Value 40.27 M
Per Share
EPS (Diluted TTM) 0.02 Revenue / Share 0.38
FCF / Share 0.10 OCF / Share 0.10
EPS CAGR (1Y) 200.00% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 116.06%
SBC-Adj. FCF 864,731 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2.66 M 570,694.0 38,000.0 120,000.0 0.0
Net Income 850,746.0 140,865.0 -24,227.0 139,682.0 -52,094.0
EPS (Diluted) 0.03 0.01 0.00 0.02 —
Gross Profit 1.58 M 377,711.0 — — —
Operating Income 1.21 M 205,629.0 -24,227.0 -13,367.0 -52,094.0
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 4,506.0 — — — —
Income Tax 353,558.0 64,869.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2.26 M 1.19 M 8,728.0 23,103.0 0.0
Total Liabilities 347,567.0 136,920.0 67,943.0 58,091.0 174,670.0
Shareholders' Equity 1.91 M 1.06 M -59,215.0 -34,988.0 -174,670.0
Total Debt — — — — —
Cash & Equivalents — — 8,728.0 23,103.0 0.0
Current Assets 2.26 M 1.19 M 8,728.0 23,103.0 0.0
Current Liabilities 347,567.0 136,920.0 67,943.0 58,091.0 174,670.0